Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cellectis (CLLS) Shares Outstanding (2017 - 2025)

Cellectis has reported Shares Outstanding over the past 9 years, most recently at $18.0 million for Q4 2025.

  • Quarterly results put Shares Outstanding at $18.0 million for Q4 2025, down 75.03% from a year ago — trailing twelve months through Dec 2025 was $18.0 million (down 75.03% YoY), and the annual figure for FY2025 was $18.0 million, down 75.03%.
  • Shares Outstanding for Q4 2025 was $10.0 million at Cellectis, down from $18.0 million in the prior quarter.
  • Over the last five years, Shares Outstanding for CLLS hit a ceiling of $71.8 million in Q4 2023 and a floor of $10.0 million in Q4 2025.
  • Median Shares Outstanding over the past 5 years was $45.5 million (2021), compared with a mean of $38.2 million.
  • Biggest five-year swings in Shares Outstanding: skyrocketed 57.09% in 2023 and later tumbled 75.03% in 2025.
  • Cellectis' Shares Outstanding stood at $45.5 million in 2021, then increased by 0.42% to $45.7 million in 2022, then skyrocketed by 57.09% to $71.8 million in 2023, then increased by 0.48% to $72.1 million in 2024, then tumbled by 75.03% to $18.0 million in 2025.
  • The last three reported values for Shares Outstanding were $18.0 million (Q4 2025), $72.1 million (Q4 2024), and $71.8 million (Q4 2023) per Business Quant data.